TokenPost
Cover art for Rhythm Pharmaceuticals Shares Rise 5.4%

Rhythm Pharmaceuticals Shares Rise 5.4%

Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target.

Nov 17, 2026

3 cards · 30s · tap to begin

From · · 30s

Rhythm Pharmaceuticals Shares Rise 5.4%

Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target.

In brief

Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target. Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17 after Eli Lilly reportedly considered acquiring the company for obesity market expansion. Originally reported by TokenPost.

Rhythm Pharmaceuticals Shares

Two unmarked medicine capsules sit on separate stone plinths / TokenPost.ai

Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17.

Eli Lilly Evaluation

Eli Lilly reportedly evaluating Rhythm Pharmaceuticals as potential obesity market acquisition target.

Viking Therapeutics Speculation

Viking Therapeutics also part of obesity market acquisition speculation.

The takeaway

Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17 after Eli Lilly reportedly considered acquiring the company for obesity market expansion.

Read the original on TokenPost

Read the TL;DR — this story on one card.

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on rhythm pharmaceuticals and related topics.